Precision Medicine Group Executive and Leadership Team

Margaret Keegan, the Chief Executive Officer at Precision Medicine Group, directs the overarching strategic vision for the organization. Overseeing the integration of clinical research and commercialization services, the Chief Executive Officer ensures that pharmaceutical clients receive seamless support from early-stage development through market entry. This leadership role involves managing a global workforce across North America, Europe, and Asia-Pacific to maintain high standards in laboratory and data science services. By aligning internal platforms with evolving biotech industry requirements, Margaret Keegan drives sustainable growth and operational excellence. The Chief Executive Officer maintains close collaboration with the Board to refine long-term objectives, ensuring that the company remains at the forefront of the life sciences sector. Through rigorous focus on client outcomes and scientific precision, the Chief Executive Officer secures the company's position as a premier partner in the drug development landscape.

Mark Clein, the Co-Founder & Chief Executive Officer at Precision Medicine Group, architects the foundational business model that supports complex drug development cycles. Focusing on the expansion of the Precision for Medicine and Precision AQ platforms, the Co-Founder & Chief Executive Officer drives the company's mission to provide specialized laboratory, genomics, and market access insights. This leadership role involves identifying strategic acquisition opportunities and fostering partnerships that enhance the firm's global footprint. By overseeing the alignment of medical communications with payer insights, Mark Clein ensures that clients navigate the commercialization process with maximum efficiency. The Co-Founder & Chief Executive Officer maintains a constant focus on scaling operations to meet the demands of the biotech industry. Through consistent innovation and a commitment to scientific rigor, the Co-Founder & Chief Executive Officer sustains the company's reputation as a leader in life sciences services.

Wendy Shusko, the Chief Financial Officer, Precision AQ at Precision Medicine Group, manages the financial health and fiscal strategy for the commercialization and market access division. Overseeing budgeting, forecasting, and resource allocation, the Chief Financial Officer, Precision AQ ensures that the division maintains profitability while delivering high-value medical communications and payer insights. This leadership role involves monitoring financial performance across international markets to support the company's broader growth objectives. By providing rigorous financial oversight, Wendy Shusko enables the division to invest in the talent and tools necessary for successful product launches. The Chief Financial Officer, Precision AQ works closely with operational leads to align spending with strategic priorities, ensuring that the firm remains competitive in the life sciences services market. Through disciplined financial management, the Chief Financial Officer, Precision AQ secures the resources required to sustain long-term excellence in client service.

Michael Winston, the Translational Sciences Chief Operating Officer & Chief Financial Officer at Precision Medicine Group, manages the intersection of scientific operations and financial performance within the translational research division. Overseeing the laboratory and genomics service lines, the Translational Sciences Chief Operating Officer & Chief Financial Officer ensures that research activities remain both scientifically rigorous and financially viable. This leadership role involves balancing the costs of advanced clinical research with the need for rapid, high-quality data delivery to biotech clients. By monitoring the fiscal health of translational projects, Michael Winston enables the company to maintain its competitive edge in the life sciences sector. The Translational Sciences Chief Operating Officer & Chief Financial Officer works with technical teams to streamline research workflows, ensuring that resources are allocated effectively to support critical drug development milestones. Through this dual focus, the Translational Sciences Chief Operating Officer & Chief Financial Officer drives both scientific and commercial success.

Chad Clark, the President & Chief Operating Officer at Precision Medicine Group, directs the day-to-day operational execution across all service platforms. Overseeing the delivery of clinical research and commercialization services, the President & Chief Operating Officer ensures that internal processes remain efficient and scalable for a diverse client base. This leadership role involves coordinating cross-functional teams to maintain high-quality standards throughout the drug development lifecycle. By optimizing operational workflows, Chad Clark supports the company's expansion into new geographic regions and market segments. The President & Chief Operating Officer collaborates with the executive team to translate strategic goals into actionable plans that drive revenue and client satisfaction. Through a focus on operational excellence and process improvement, the President & Chief Operating Officer ensures that the organization consistently meets the complex needs of pharmaceutical and biotech partners on a global scale.

Othniel Badea, the Chief Technology Officer at Precision Medicine Group, directs the digital infrastructure and data science capabilities that underpin clinical research services. Overseeing the development of proprietary platforms, the Chief Technology Officer ensures that genomics and laboratory data remain secure, accessible, and actionable for pharmaceutical clients. This leadership role involves integrating advanced analytics into the drug development workflow to improve decision-making speed and accuracy. By managing the technical teams responsible for data integrity, Othniel Badea supports the company's global operations across diverse geographic markets. The Chief Technology Officer collaborates with other C-suite leaders to implement scalable solutions that address the unique challenges of modern biotech research. Through the deployment of cutting-edge technology, the Chief Technology Officer optimizes internal processes, directly contributing to the efficiency of the entire organization and the success of client-facing projects.

David Winn, the Chief Administrative Officer, Clinical Solutions at Precision Medicine Group, directs the administrative functions and organizational support structures for the clinical research division. Overseeing human resources, facilities, and internal compliance, the Chief Administrative Officer, Clinical Solutions ensures that the clinical teams operate within a framework that promotes efficiency and regulatory adherence. This leadership role involves managing the logistical requirements of a large, distributed workforce to maintain high productivity across global sites. By streamlining administrative processes, David Winn enables the clinical solutions team to focus entirely on the complexities of drug development and client service. The Chief Administrative Officer, Clinical Solutions collaborates with other executives to foster a culture of operational excellence and professional development. Through the effective management of administrative resources, the Chief Administrative Officer, Clinical Solutions supports the company's mission to provide world-class clinical research services to the pharmaceutical industry.

Eric Hodgins, the Chief Information & Technology Officer at Precision Medicine Group, directs the enterprise-wide information systems and technological innovation strategy. Overseeing the security and scalability of the company's digital infrastructure, the Chief Information & Technology Officer ensures that global teams have the tools required to manage complex clinical data. This leadership role involves implementing robust cybersecurity measures and cloud-based solutions that protect sensitive pharmaceutical research. By aligning technology investments with the company's business model, Eric Hodgins supports the seamless delivery of services across North America, Europe, and Asia-Pacific. The Chief Information & Technology Officer collaborates with other leaders to modernize internal systems, fostering an environment of digital agility. Through the strategic application of information technology, the Chief Information & Technology Officer enhances the firm's ability to process data efficiently, ultimately accelerating the pace of drug development for all clients.